Obese subjects frequently exhibit metabolic disorders together with elevated inflammatory markers, such as the C-reactive protein (CRP) and alanine transferase (ALT), markers associated with an increased risk of cardiovascular disease and liver damage. Here, CRP is linked to metabolic disease.